In this review, the continuing importance and status of development of radionuclide
generator systems for nuclear medicine are discussed. Radioisotope costs and availability …

Rhenium-188 is one of the most readily available generator derived and useful
radionuclides for therapy emitting β-particles (2.12 MeV, 71.1% and 1.965 MeV, 25.6%) and …

Radiopharmaceuticals, drugs containing a radionu-clide, are used routinely in nuclear
medicine depart-ments for the diagnosis of disease and are under investigation for use in …

The chelating thiols dimercaptosuccinate (DMSA) and dimercaptopropane sulfonate
(DMPS) are effective in enhancing urinary excretion of mercury and lead. However …

The development of an in-house 188W/188Re-generator has greatly increased the use of
188Re for treating various diseases. 188Re is of widespread interest due to its attractive …

Pentavalent rhenium-188 dimercaptosuccinic acid [188 Re (V) DMSA] is a β-emitting
analogue of 99m Tc (V) DMSA, a tracer that is taken up in a variety of tumours and bone …

A novel procedure for the high-yield preparation of Re-188 radiopharmaceuticals containing
a terminal Re≡ N multiple bond is described. This method involves the reaction of …

Bone pain arising from secondary skeletal malignancy constitutes one of the most common
types of chronic pain among patients with cancer which can lead to rapid deterioration of the …

Complexes labeled with 186 Re and 188 Re have been developed for the radiotherapy
treatment of diseases because of the desirable nuclear properties of these radioisotopes …

Abstract Technetium-99m (99m Tc) is currently, and will be in the foreseeable future, the
most widely used radionuclide used in virtually all clinical diagnostic Nuclear Medicine …